New 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline.

The new American College of Cardiology/American Heart Association 2017 Hypertension Guidelines lower the threshold to define hypertension, thus increasing its prevalence. The impact on populations and health systems is poorly understood. We included data from 990 subjects aged 20 to 64 years from the SALMEX cohort (Salt in Mexico; Mexico City) and determined the prevalence of hypertension and requirement for pharmacological treatment according to both Joint National Committee on the Prevention, Detection, and Treatment of High Blood Pressure 7 and American College of Cardiology/American Heart Association 2017 guidelines. The data obtained were extrapolated to sex- and age-adjusted Mexico City population, and annual costs of medical follow-up were calculated. The new definition increased the prevalence of hypertension among SALMEX cohort from 16.2% to 37.4% (18%-39.3% after adjusting to Mexico City population). The proportion of subjects that require pharmacological and nonpharmacological treatment increased from 17.7% to 19.0% and from 17.7% to 37.4%, respectively (19.4%-21.8% for pharmacological and 19.4%-39.3% for nonpharmacological treatment, after adjusting to Mexico City population). Annual costs of medical follow-up for subjects with hypertension in Mexico City would increase an estimated $59 278 928. The requirement to initiate pharmacological treatment was similar when assessed by Framingham risk score with lipids or with body mass index compared with the Atherosclerotic Cardiovascular Disease score, with correlation κ indexes of 0.981 and 0.972, respectively. On the basis of these results, Framingham body mass index represents an attractive and potentially cost-effective alternative to assess cardiovascular risk. In conclusion, the adoption of the new guidelines in Mexican population has implications not only on its prevalence but also on medical follow-up costs. A pharmacoeconomic model is required to assess the actual financial impact.

Assessment of the reliability and consistency of the "malnutrition inflammation score" (MIS) in Mexican adults with chronic kidney disease for diagnosis of protein-energy wasting syndrome (PEW).

BACKGROUND: The protein-energy wasting syndrome (PEW) is a condition of malnutrition, inflammation, anorexia and wasting of body reserves resulting from inflammatory and non-inflammatory conditions in patients with chronic kidney disease (CKD).One way of assessing PEW, extensively described in the literature, is using the Malnutrition Inflammation Score (MIS). OBJECTIVE: To assess the reliability and consistency of MIS for diagnosis of PEW in Mexican adults with CKD on hemodialysis (HD). METHODS: Study of diagnostic tests. A sample of 45 adults with CKD on HD were analyzed during the period June-July 2014.The instrument was applied on 2 occasions; the test-retest reliability was calculated using the Intraclass Correlation Coefficient (ICC); the internal consistency of the questionnaire was analyzed using Cronbach's αcoefficient. A weighted Kappa test was used to estimate the validity of the instrument; the result was subsequently compared with the Bilbrey nutritional index (BNI). RESULTS: The reliability of the questionnaires, evaluated in the patient sample, was ICC=0.829.The agreement between MIS observations was considered adequate, k= 0.585 (p <0.001); when comparing it with BNI, a value of k = 0.114 was obtained (p <0.001).In order to estimate the tendency, a correlation test was performed. The r² correlation coefficient was 0.488 (P <0.001). CONCLUSION: MIS has adequate reliability and validity for diagnosing PEW in the population with chronic kidney disease on HD.

Antecedentes: El síndrome de desgaste proteínico-energético (DPE) se refiere a una condición de desnutrición, inflamación, anorexia, y emaciación de reservas corporales resultante de las condiciones inflamatorias y no inflamatorias que prevalecen en pacientes con enfermedad renal crónica (ERC).Una forma ampliamente descrita en la literatura para evaluar el DPE es el Malnutrition Inflamation Score (MIS). Objetivo: Valorar la fiabilidad y consistencia del MIS en adultos mexicanos con ERC en Hemodiálisis (HD) para Diagnóstico de DPE. Métodos: Estudio de pruebas diagnósticas. Se analizó una muestra de 45 adultos con ERC en HD, Durante el periodo Junio-Julio 2014. El instrumento se aplicó en 2 ocasiones, la fiabilidad test-retest se calculó mediante el Coeficiente de correlación Intraclase (CCI), la consistencia interna del cuestionario se analizó mediante el Coeficiente de Cronbach. Se calculó una prueba de Kappa ponderada para estimar la validez del instrumento, posteriormente se comparó con el índice nutricional de Bilbrey (IB). Resultados: La fiabilidad entre cuestionarios valorada en la muestra de pacientes fue de CCI = 0.829. La concordancia entre observaciones MIS es considerada como adecuada = 0.585 (p.